VSL#3 probiotic differently influences IEC-6 intestinal epithelial cell status and function

Area of Science:

• Gastroenterology
• Cell Biology
• Microbiology

Background:

• Probiotics offer potential benefits for gastrointestinal mucosal health.
• Manufacturing consistency is critical for ensuring probiotic product efficacy.
• Variations in probiotic formulations may impact their protective effects.

Purpose of the Study:

• To evaluate the in vitro efficacy of two VSL#3 probiotic formulations from different production sites (USA and Italy).
• To assess the impact of these formulations on small intestinal epithelial cell line (IEC-6) integrity and repair.
• To introduce the wound-healing assay as a tool for testing probiotic manufacturing consistency.

Main Methods:

• Comparison of USA-made and Italy-made VSL#3 formulations using IEC-6 cells.
• Assessment of cellular morphology, viability, migration, and response to hydrogen peroxide (H₂O₂) induced damage.
• Evaluation of wound healing, stress fiber formation, and reactive oxygen species (ROS) generation.

Main Results:

• Italy-made VSL#3 caused cell damage and reduced cellularity, unlike the USA-made formulation.
• USA-made VSL#3 lysate significantly enhanced wound healing and stress fiber formation.
• USA-made VSL#3 lysate provided complete protection against H₂O₂-induced cytotoxicity and modulated ROS generation, while the Italy-made formulation did not.

Conclusions:

• The USA-made VSL#3 formulation exhibits superior protective and healing properties for intestinal epithelial cells in vitro.
• Significant differences exist between VSL#3 products from different manufacturing sites, highlighting the importance of quality control.
• The wound-healing assay is a valuable tool for assessing probiotic efficacy and manufacturing consistency.